Abstract
BackgroundReduced calorie, low fat diet is currently recommended diet for overweight and obese adults. Prior data suggest that low carbohydrate diets may also be a viable option for those who are overweight and obese.PurposeCompare the effects of low carbohydrate versus low fats diet on weight and atherosclerotic cardiovascular disease risk in overweight and obese patients.Data SourcesSystematic literature review via PubMed (1966–2014).Study SelectionRandomized controlled trials with ≥8 weeks follow up, comparing low carbohydrate (≤120gm carbohydrates/day) and low fat diet (≤30% energy from fat/day).Data ExtractionData were extracted and prepared for analysis using double data entry. Prior to identification of candidate publications, the outcomes of change in weight and metabolic factors were selected as defined by Cochrane Collaboration. Assessment of the effects of diets on predicted risk of atherosclerotic cardiovascular disease risk was added during the data collection phase.Data Synthesis1797 patients were included from 17 trials with <1 year follow up in 12. Compared with low fat diet, low carbohydrate was associated with significantly greater reduction in weight (Δ = -2.0 kg, 95% CI: -3.1, -0.9) and significantly lower predicted risk of atherosclerotic cardiovascular disease events (p<0.03). Frequentist and Bayesian results were concordant. The probability of greater weight loss associated with low carbohydrate was >99% while the reduction in predicted risk favoring low carbohydrate was >98%.LimitationsLack of patient-level data and heterogeneity in dropout rates and outcomes reported.ConclusionsThis trial-level meta-analysis of randomized controlled trials comparing LoCHO diets with LoFAT diets in strictly adherent populations demonstrates that each diet was associated with significant weight loss and reduction in predicted risk of ASCVD events. However, LoCHO diet was associated with modest but significantly greater improvements in weight loss and predicted ASCVD risk in studies from 8 weeks to 24 months in duration. These results suggest that future evaluations of dietary guidelines should consider low carbohydrate diets as effective and safe intervention for weight management in the overweight and obese, although long-term effects require further investigation.
Highlights
Low-fat diets were advocated based on associations between dietary fat intake and cardiovascular risk[1] yet three lines of evidence suggest that low-fat diets might not be optimum for weight management
Lack of patient-level data and heterogeneity in dropout rates and outcomes reported. This trial-level meta-analysis of randomized controlled trials comparing LoCHO diets with LoFAT diets in strictly adherent populations demonstrates that each diet was associated with significant weight loss and reduction in predicted risk of atherosclerotic cardiovascular disease (ASCVD) events
LoCHO diet was associated with modest but significantly greater improvements in weight loss and predicted ASCVD risk in studies from 8 weeks to 24 months in duration. These results suggest that future evaluations of dietary guidelines should consider low carbohydrate diets as effective and safe intervention for weight management in the overweight and obese, long-term effects require further investigation
Summary
Low-fat diets were advocated based on associations between dietary fat intake and cardiovascular risk[1] yet three lines of evidence suggest that low-fat diets might not be optimum for weight management. The Cochrane Collaboration review demonstrated over a decade ago that low-fat diets were not associated with clinically meaningful advantages in weight loss compared with caloric restriction after 6, 12 and 18 months.[2] Second, clinical trial evidence available in 1983 for the initial US and UK dietary guidelines did not demonstrate the superiority of low fat diets as first line for those overweight or obese.[3] And third, the large-scale randomized Women’s Health Initiative trial failed to show impact of low-fat diets on clinical outcomes,[4] with modest changes in lipid profiles and weight.[5,6].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.